Adverse events1,656

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,656

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Abdominal distension	Gastrointestinal disorders	GROUP 1: Cohort 1, Dose Level 1, 3 x10^5 Transduced T Cells/kg (+Or-20%)	0	4	0
other	Abdominal distension	Gastrointestinal disorders	GROUP 2: Cohort 1, Dose Level 2, 1x10^6 Transduced T Cells/kg (+Or-20%)	0	4	0
other	Abdominal distension	Gastrointestinal disorders	GROUP 3: Cohort 1, Dose Level 3, 3 x10^6 Transduced T Cells/kg (+Or-20%)	0	4	0
other	Abdominal distension	Gastrointestinal disorders	GROUP 4: Cohort 1A, Dose Level 3, 3 x10^6 Transduced T Cells/kg (+Or-20%)	0	2	0
other	Abdominal distension	Gastrointestinal disorders	GROUP 5: Cohort 1B, Dose Level 3, 3 x10^6 Transduced T Cells/kg (+Or-20%)	0	1	0
other	Abdominal distension	Gastrointestinal disorders	GROUP 6: Cohort 2A, Dose Level 3, 3 x10^6 Transduced T Cells/kg (+Or-20%)	4	21	5
other	Abdominal distension	Gastrointestinal disorders	GROUP 7: Cohort 2B, Dose Level 3, 3 x10^6 Transduced T Cells/kg (+Or-20%	0	1	0
other	Abdominal distension	Gastrointestinal disorders	Group 8:Cohort 2C, CAR Naïve or CAR Pretreated With Previous Hematopoietic Stem Cell Transplantation	0	1	0
other	Abdominal pain	Gastrointestinal disorders	GROUP 1: Cohort 1, Dose Level 1, 3 x10^5 Transduced T Cells/kg (+Or-20%)	2	4	3
other	Abdominal pain	Gastrointestinal disorders	GROUP 2: Cohort 1, Dose Level 2, 1x10^6 Transduced T Cells/kg (+Or-20%)	2	4	3
other	Abdominal pain	Gastrointestinal disorders	GROUP 3: Cohort 1, Dose Level 3, 3 x10^6 Transduced T Cells/kg (+Or-20%)	2	4	6
other	Abdominal pain	Gastrointestinal disorders	GROUP 4: Cohort 1A, Dose Level 3, 3 x10^6 Transduced T Cells/kg (+Or-20%)	2	2	4
other	Abdominal pain	Gastrointestinal disorders	GROUP 5: Cohort 1B, Dose Level 3, 3 x10^6 Transduced T Cells/kg (+Or-20%)	1	1	1
other	Abdominal pain	Gastrointestinal disorders	GROUP 6: Cohort 2A, Dose Level 3, 3 x10^6 Transduced T Cells/kg (+Or-20%)	10	21	17
other	Abdominal pain	Gastrointestinal disorders	GROUP 7: Cohort 2B, Dose Level 3, 3 x10^6 Transduced T Cells/kg (+Or-20%	0	1	0
other	Abdominal pain	Gastrointestinal disorders	Group 8:Cohort 2C, CAR Naïve or CAR Pretreated With Previous Hematopoietic Stem Cell Transplantation	0	1	0
other	Activated partial thromboplastin time prolonged	Investigations	GROUP 1: Cohort 1, Dose Level 1, 3 x10^5 Transduced T Cells/kg (+Or-20%)	1	4	2
other	Activated partial thromboplastin time prolonged	Investigations	GROUP 2: Cohort 1, Dose Level 2, 1x10^6 Transduced T Cells/kg (+Or-20%)	1	4	1
other	Activated partial thromboplastin time prolonged	Investigations	GROUP 3: Cohort 1, Dose Level 3, 3 x10^6 Transduced T Cells/kg (+Or-20%)	2	4	4
other	Activated partial thromboplastin time prolonged	Investigations	GROUP 4: Cohort 1A, Dose Level 3, 3 x10^6 Transduced T Cells/kg (+Or-20%)	1	2	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03448393/events

API reference For AI assistants

Adverse events1,656

Sources 3

Read this list from software.